Posted on 05/19/2020 7:35:43 PM PDT by Aquamarine
According to the Department of Health and Human Services, the contract with Phlow Corp. will reduce the United States’ dependence on imported drugs.
BARDA, the Biomedical Advanced Research and Development Authority, announced May 19 that it awarded a $354 million manufacturing contract to Phlow Corp., a generic drug manufacturing company. The contract aims to shore up a domestic supply source for essential pharmaceuticals, some of which are currently being used to fight the novel coronavirus COVID-19. The four-year contract also includes, as an option, a “long-term sustainability” option of an additional $458 million.
BARDA Acting Director Dr. Gary Disbrow, in a statement, said “collaborating with Phlow and its partners is an important step in expanding our manufacturing of APIS”—active pharmaceutical ingredients—“and critical medicines at-risk of shortage.”
Phlow, which is based in Richmond, Virginia, is a pharmaceutical startup company that aims to “reduce the U.S.’s dependency on foreign supply chains,” according to its website. The company will work alongside private-sector partners Civica Rx, Virginia Commonwealth University’s Medicines for All Institute, and AMPAC Fine Chemicals in order to fill the contract. According to Phlow, the money from the contract has already resulted in the delivery of over 1.6 million doses of generic drugs used to fight COVID-19 to the U.S.'s Strategic National Stockpile. Those included antibiotics, sedatives, and painkillers.
The company will use “continuous advanced manufacturing processes to help manufacture its API.” While the process reportedly “has not been widely adopted,” according to Phlow, it has the potential to “increase the quality, safety, and volume of medicines” and lower costs.
(Excerpt) Read more at industryweek.com ...
Do we get money back when the drugs sell?
Liberals will find something to hate about this, too.
A very good idea to start rebuilding our medical independence or whatever it’s best called. (I hope the company is competent and that there’s no improper associations.)
What’s the stock symbol for Phlow??
$354 Million...a nice target for Democrat Trial Lawyers. The TV ads will follow shortly.
It is privately held though who knows perhaps in the future
Excuse my shouting....ABOUT FRICKIN’ TIME.
One of the co-founders is a Bill Gates foundation recipient.
Other than that, this is a needed company. Looks like so far it’s a private company.
Yay!!!
It's a contract. They are producing drugs. That's what we get.
fascinating ... this company was formed specifically to be awarded this contract!
https://www.phlow-usa.com/about-us/
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.